After completion of this program, participants will be able to:
- Discuss options to address the proper management of common clinical situations related to the use of biologic drugs for immune-mediated inflammatory diseases
- Demonstrate improved communication with patients on biologics and thus empower them in the self-management of their disease
- Apply relevant and current guidelines in management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, Crohn’s disease and psoriasis when communicating with patients on optimal risks and benefits of biologics
- Recognize the difference between biologics and biosimilars